Alcon launches Clareon PanOptix Pro in Europe at ESCRS2026
The new product is now commercially available, showcased during the London conference to highlight surgical innovations and future eye care advancements.
See the latest news and media coverage for Alcon. We track all announcements, press releases, and industry mentions in real time, all in one place.
Eye care company specializing in surgical and vision care products
alcon.comLast updated
In short: Alcon reported strong Q2 2026 growth, raised its full-year guidance, and launched the UNITY surgical ecosystem and Clareon TruPlus IOL.
The new product is now commercially available, showcased during the London conference to highlight surgical innovations and future eye care advancements.
The debt carries a 3.875 percent interest rate and matures in 2033. Proceeds will fund general corporate purposes and refinance existing obligations.
The non-exclusive agreement aims to combine Alcon's PCIOL optics with RxSight's light-adjustable platform for post-surgery vision fine-tuning.
The report highlights exceeding goals in children's vision screenings, cataract care, R&D investment, and emissions reductions.
Alcon stock is trading around USD 66 after Q2 2026 earnings showed EPS of USD 0.84 and a raised 2026 profit outlook. Analysts ...
These new participants are Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals and UCB, according to a White House release...
Alcon stock reacts to US Medicaid drug pricing agreement New US Medicaid drug pricing agreements involving Alcon (SWX:ALC) and eight other healthcare...
The billionaire's new stakes in Netflix, Visa, and four others sent most shares higher; he favors high-quality growth companies.
Track Alcon and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Alcon and other trending companies.